GGenetics Read More Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue EstimatesAugust 13, 2025 Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus…